Synapse - Find an Expert

5608 Results

Optimization of biodistribution parameters for radioimmunotherapy: Clinical trial with HuJ591

Meeting Abstract

Pandit-Taskar, N.; Morris, M. J.; Batraki, M.; Perez, A.; Nacca, A.; Smith-Jones, P.; Halpern, J.; Finn, R.; Scher, H. I.; Bander, N. H.; more...
Journal of Nuclear Medicine (2003)

Fulltext@MSK | Save

Tumor localization of [18F]-Fluoro-Dihydro-testosterone (FDHT) versus [18F]-2-Fluoro-D-glucose (FDG) in patients with progressive, metastatic prostate cancer

Meeting Abstract

Larson, S. M.; Gunther, I.; Morris, M.; Beattie, B.; Akhurst, T. A.; Finn, R.; Pentlow, K.; Zanzonico, P.; Erdi, Y.; Humm, J.; more...
Journal of Nuclear Medicine (2003)

Fulltext@MSK | Save

Transcriptional programs affected by androgen ablation therapy and the development of therapy resistant prostate cancer

Meeting Abstract

Lal, P.; Holzbeierlein, J.; LaTulippe, E.; Satagopan, J.; Smith, A.; Ryan, C.; Scher, H.; Scardino, P.; Reuter, V.; Gerald, W.
Laboratory Investigation (2003)

Fulltext@MSK | Save

Transcriptional programs affected by androgen ablation therapy and the development of therapy resistant prostate cancer

Meeting Abstract

Lal, P.; Holzbeierlein, J.; LaTulippe, E.; Satagopan, J.; Smith, A.; Ryan, C.; Scher, H.; Scardino, P.; Reuter, V.; Gerald, W.
Modern Pathology (2003)

Fulltext@MSK | Save

Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SAHA)

Meeting Abstract

Kelly, W. K.; O'connor, O.; Richon, V. M.; Curley, T.; Richardson, S.; Thapi, D.; Chiao, J. H.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
Clinical Cancer Research (2003)

Fulltext@MSK | Save

Activated, mutated B-Raf protein kinase requires the Hsp90 chaperone protein for folding and stability and is degraded in response to Hsp90 inhibitors